Clinical Trial: Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers

U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963411) titled 'Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers' on April 24.

Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of several KP001 dose regimens to identify a treatment regimen with a PK profile that safely meets or exceeds the PK profile of existing injected epinephrine products. The main questions it aims to answer are:

* To evaluate any carryover effect with a 7-day washout of different dose regimens of KP001 in healthy adult volunteers.

* To evaluate the safety, tolerability and PK of different do...